A Randomized, Fed, Open-label, Crossover Clinical Study to compare Pharmacokinetics and Safety of WIP-DF17 for Single Dose in Healthy Adult Subjects.
Latest Information Update: 05 Feb 2020
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Whanin Pharmaceutical
Most Recent Events
- 05 Feb 2020 New trial record